Ketamine, a Schedule III non-narcotic substance, has been available to licensed prescribers since the 1970s. Since then, multiple studies have shown ketamine helps some depression patients who feel as though they’ve tried everything else.
Dr. Jonathan Lewin is stepping down as Emory Healthcare CEO and chairman after six years — a period that saw strong growth in the Atlanta-based system.
Just 3% of venture capital in the United States goes to underrepresented minority entrepreneurs. Emory University’s Goizueta School of Business is looking to change that dynamic with a new student-led venture capital fund.
Drug company Merck is awaiting word on its emergency use authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.
Researchers at Atlanta’s Emory University were the ones who invented a promising antiviral drug in the fight against COVID-19 — a pill that pharmaceutical giant Merck & Co. said on Friday reduced hospitalizations and deaths by half in people recently infected with the coronavirus.
Researchers at Emory University's Brain Health Center hope to better understand the root causes of dementia diseases such as Alzheimer's and mental health disorders such as depression by examining individual patients' biological, medical and lifestyle factors.
Dr. Allan Levey is leading the Brain Health Personalized Medicine Institute at Emory University.
A drug developed at Emory University will now be manufactured by Merck in India. The hope is to stop the rapid spread of COVID-19 in the country, whose health system is on the verge of collapse.
Racist encounters have become increasingly common for Asian American and international students in the era of President Donald Trump, with hate speech intensifying ever since the novel coronavirus arrived in the United States in early 2020, students at Emory University in Atlanta told GPB News.
Doctors at Emory University on Monday celebrated the news from biotech company Moderna that its COVID-19 vaccine is 94.5% effective, saying the breakthrough is a historic day for science and that the next frontier will be to convince Americans to take it when the vaccine becomes available.
The nation’s leading infectious disease doctor issued a strong rebuke of the White House on Thursday, saying he would not support political meddling in the rush to make a coronavirus vaccine available to the American public.
When Norman Hulme heard Emory was opening its vaccine trial to people age 56 and over, he jumped at the chance. The 65-year-old grew up in New York, in...
If you're going out to celebrate the Fourth of July holiday, wear a mask. If you want to save the economy and prevent the need for shutting down the...
Over the weekend Georgia saw its largest spike in coronavirus cases since the pandemic began, with experts warning about an alarming rise in the state's...
